The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting ... CFO David Denton said the company is already expecting a $150 million impact in 2025 from the current slate of tariffs but did ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Pfizer CEO Albert Bourla on Tuesday said ... the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer reaffirming its outlook for the full year but noting it has not factored in any potential impact from tariffs. Here to discuss what these results mean for the drug maker we've got Vamul Divan.

On the call, Pfizer CEO Albert Bourla said the company established a team to analyze a range of potential outcomes and develop strategies to help mitigate the potential impact of tariffs on its ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...